Using big data for computational modeling of infectious diseases
FRED uses census-based synthetic populations that capture the demographic, household, school, and workplace distributions of the U.S. population. FRED can generate an agent-based model for any county in the U.S.
FRED incorporates data from detailed vaccine and anti-viral delivery schedules and simulate multi-strain pathogens. Mitigation strategies can include vaccination, anti-viral drugs, and school closure policies. FRED includes models of health behavior change to demonstrate effects of vaccine acceptance, anti-viral use and spontaneous social distancing.
FRED can be run locally or accessed through an interface that permits users to run simulations remotely. A FRED Navigator is being developed for applications in high schools and research institutions. This session will describe how, by making FRED available, the University of Pittsburgh MIDAS National Center of Excellence, makes large-scale agent-based epidemic models more useful to the policy-making community, the research community, and as a teaching tool for students.
Learning Areas:Conduct evaluation related to programs, research, and other areas of practice
Protection of the public in relation to communicable diseases including prevention or control
Public health or related research
Systems thinking models (conceptual and theoretical models), applications related to public health
Explain an advantage to modeling over traditional analytic methods. Identify agent-based modeling as a tool to aid public health decision making.
Keyword(s): Decision-Making, Infectious Diseases
Qualified on the content I am responsible for because: I am staff to the MIDAS Center of Excellence at the University of Pittsburgh. The Center of Excellence is one of two in the national MIDAS network. I am familiar with the MIDAS network, its research, and outcomes.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.